Skip to content
Magazine
Advertisements
Issues
Savings Card
Events
News
Artificial Intelligence
Funding
Pharmacies
Medical Devices
Medical Technology
Pharma and Biotech
NGOs
Investments
Mergers and Acquisitions
Hospitals
About Us
Videos
AI Chat Bot
Magazine
Advertisements
Issues
Savings Card
Events
News
Artificial Intelligence
Funding
Pharmacies
Medical Devices
Medical Technology
Pharma and Biotech
NGOs
Investments
Mergers and Acquisitions
Hospitals
About Us
Videos
AI Chat Bot
Search
$
0.00
0
Cart
Pharma and Biotech
Mergers and Acquisitions
,
Pharma and Biotech
Bristol Myers Squibb to acquire 2seventy Bio in US $286M deal
Pharma and Biotech
Zealand and Roche partner in US $5.3 billion obesity drug deal
Healthcare Delivery
,
Pharma and Biotech
New oral treatment for endometriosis approved for NHS use
Pharma and Biotech
J&J backs new oral drug for psoriasis with head-to-head trial
Healthcare Delivery
,
Pharma and Biotech
Big Pharma calls for action to tackle NCD crisis
Pharma and Biotech
Merck opens US $1 billion facility to boost bladder cancer treatment
Pharma and Biotech
EU approves AstraZeneca and Ionis’ Wainzua for rare nerve disease
Mergers and Acquisitions
,
Pharma and Biotech
Sun Pharma strengthens oncology pipeline with US $355M Checkpoint deal
Pharma and Biotech
Novo Nordisk’s CagriSema shows promising weight loss, but investors remain unimpressed
Medical Technology
,
Pharma and Biotech
J&J halts depression drug development after poor trial results
Pharma and Biotech
NAFDAC addresses concerns over counterfeit drugs and leprosy medication delays
Appointments
,
Artificial Intelligence
,
Pharma and Biotech
Pfizer’s former R&D chief Mikael Dolsten joins Immunai’s board
